Femoral remodeling after porous-coated total hip arthroplasty with and without hydroxyapatite-tricalcium phosphate coating: a prospective randomized trial

J Arthroplasty. 2001 Aug;16(5):552-8. doi: 10.1054/arth.2001.23721.

Abstract

We prospectively assessed femoral bone remodeling using dual-energy x-ray absorptiometry for 2 years after total hip arthroplasty. Thirty-nine hips were randomized to receive a titanium proximally porous-coated femoral component with or without hydroxyapatite-tricalcium phosphate coating. Although both stems resulted in alterations in the periprosthetic bone mineral density, the hydroxyapatite-tricalcium phosphate coated stems had significantly less femoral bone loss than the uncoated stems at 2-year follow-up. This reduced femoral bone loss may provide short-term and long-term advantages over noncoated stems.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Absorptiometry, Photon
  • Analysis of Variance
  • Arthroplasty, Replacement, Hip*
  • Bone Density
  • Bone Remodeling / physiology*
  • Calcium Phosphates
  • Coated Materials, Biocompatible
  • Durapatite
  • Femur / physiology*
  • Hip Prosthesis*
  • Humans
  • Prospective Studies
  • Prosthesis Design
  • Titanium
  • Treatment Outcome

Substances

  • Calcium Phosphates
  • Coated Materials, Biocompatible
  • beta-tricalcium phosphate
  • Durapatite
  • Titanium
  • tricalcium phosphate